ATHA - Athira Pharma Inc Qarzning balans kapitallashuviga nisbati
Athira Pharma, Inc. (ATHA) Parkinson va Altsgeymer kasalliklariga qarshi kurashish uchun ilg'or neyron aloqalarini regeneratsiya qilish usullarini ishlab chiqmoqda. Ushbu bozorning ulkan salohiyati yangi farmatsevtika preparatlariga bo'lgan ulkan talabni oshirmoqda. Kompaniyaning daromadi miyani tiklash uchun kichik molekulalarni tijoratlashtirishga asoslangan. GURU.Markets platformasidagi ushbu grafikni tahlil qilib, qarzning kapitalizatsiyaga nisbati 0.03 ekanligini ko'rishimiz mumkin.
%20Qarzning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_ATHA_-_Athira-Pharma-Inc._-_Debt-to-Net-Assets-Ratio "Athira Pharma - ATHA Qarzning balans kapitallashuviga nisbati (davr: 04.07.2022 - 12.01.2026) | 👁️GURU.Markets👁️")
Athira Pharma Inc (ATHA) kompaniyasi koʻrsatkichlari kesimi va tahlili
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Athira Pharma, Inc.|ATHA - Uzoq muddatli kreditlarning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Athira|ATHA - Jamlangan qarz majburiyatlari|Balans kapitallashuviga qarzlar Athira Pharma Corp|ATHA - Uzoq muddatli qarz hajmi|Kompaniyaning qisqa muddatli qarzi Athira Pharma
Kompaniyaning fundamental tahlili:Athira Pharma, Inc.
Athira Pharma, Inc. (ATHA) moliyaviy barqarorligini qarz va kapital muvozanati orqali baholang. Ushbu ko'rsatkich leveraj darajasini aniqlash uchun umumiy majburiyatlarni kapitalning balans qiymati bilan solishtiradi. Majburiyatlarning kapitalizatsiya balans qiymatiga nisbatdagi joriy ko'rsatkichini tahlil qilish orqali investor biznesning kreditorlarga bo'lgan bog'liqlik darajasini aniqlashi mumkin. Neyron regeneratsiyasi sohasidagi innovator uchun past qarz miqdori juda muhimdir, chunki bu qimmatga tushadigan Altsgeymer kasalligi tadqiqotlarining avtonomligini ta'minlaydi.
Athira Pharma, Inc. kimlar bilan raqobatlashadi
Qarzning balans qiymatiga nisbati BIIB (Biogen Inc.)|neurocrine.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Regencell Bioscience Holdings Limited (RGC)|AXSM: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati ACAD|Xenon Corp (XENE) - Balans qiymatiga qarzlar|VKTX (Viking Therapeutics) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar supernus.com (SUPN)|Qarzning balans qiymatiga nisbati Catalyst Pharmaceuticals, Inc.|Qarzning balans kapitaliga nisbati Denali (DNLI)|Balans kapitallashuviga qarzlar Harmony Pharma|Qarzning sof aktivlarga nisbati Biohaven Corp BHVN|Balans kapitallashuviga qarzlar AMLX (Amylyx Pharmaceuticals)|TRVI: Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati Praxis Precision Medicines, Inc. PRAX|Anavex (AVXL) - Qarzning sof aktivlarga nisbati|CBLL (CeriBell Corp) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar prothena.com (PRTA)|Alector, Inc. (ALEC) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati ANNX (annexonbio.com)|Omeros (OMER) - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati Neurogene Inc NGNE|Balans kapitallashuviga qarzlar AC Immune Corp (ACIU)|VYGR - Qarzning sof aktivlarga nisbati|NMRA: Balans kapitallashuviga qarzlar|SCLX (scilexholding.com) - Balans kapitallashuviga qarzlar|TVGN - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati ACOG|Qarzning balans kapitallashuviga nisbati CGTX (Cognition Therapeutics)|Qarzning balans qiymatiga nisbati Inhibikase Pharma (IKT)|Balans kapitallashuviga qarzlar SAVA (Cassava Sciences, Inc.)|ASRT - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Coya (COYA)|VTGN - Qarzning sof aktivlarga nisbati|ovidrx.com - Balans kapitallashuviga qarzlar|ABOS (Acumen Pharmaceuticals, Inc) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati CervoMed Inc. (CRVO)|Qarzning balans qiymatiga nisbati Alterity Therapeutics Ltd|Balans kapitallashuviga qarzlar CLNN (Clene Inc.)|Qarzning balans qiymatiga nisbati pepgen.com PEPG|Qarzning balans qiymatiga nisbati JUNS|Sof aktivlarga qarzlar Relmada Corp RLMD|Annovis Bio, Inc. - Balans kapitallashuviga qarzlar|Grace Therapeutics, Inc. (GRCE) - Balans kapitallashuviga qarzlar|AIFF - Qarzning balans qiymatiga nisbati|Klotho Neurosciences (KLTO) - Qarzning balans kapitaliga nisbati|NRSN - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Reviva Pharmaceuticals, Inc.|Balans kapitallashuviga qarzlar MTVA|Balans kapitallashuviga qarzlar NRXS (neuraxis.com)|HSDT - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Passage Bio Inc. PASG|NEUP (Neuphoria) - Balans kapitallashuviga qarzlar|Minerva (NERV) - Balans qiymatiga qarzlar|ADXN: Qarzning balans qiymatiga nisbati|ALZN (Alzamend Neuro) - Balans kapitallashuviga qarzlar|CYCN - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati PTIX|Pasithea Therapeutics - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar cortigent.com (CRGT)|Balans kapitallashuviga qarzlar ATXI (Avenue Therapeutics)|BCLI - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Cara Therapeutics CARA|CHRO - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar eliemtx.com ELYM|Intra-Cellular Therapies, Inc. (ITCI) - Qarzning sof aktivlarga nisbati|LBPH: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar MRNS|NKGen Biotech (NKGN) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati NeuroBo Pharmaceuticals Inc (NRBO)|Balans kapitallashuviga qarzlar SAGE (Sage Therapeutics, Inc)|SNPX - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Trevena, Inc. (TRVN)|VIGL: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Anew Medical (WENA)|Cerevel Therapeutics Inc (CERE) - Qarzlarning balans kapitallashuviga nisbati